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Abstract: A 57-year-old woman consulted our department about a plaque that had been present 
in her left eye for one year. Ophthalmological examination revealed a solid mass in the left con-
junctival semilunar fold. An excitional biopsy was peformed, revealing an amyloid deposition. 
The patient was referred to the Internal Medicine Department for systemic study. All studies 
were negative for systemic amyloidosis. Throughout ten years of follow-up study, the patient 
has shown neither conjunctival recurrence nor any evidence of systemic amylodosis. Despite the 
fact that several authors have described ocular amyloidosis as an ophthalmologic manifestation 
of systemic amyloidosis, conjunctival location of amyloidosis is a very rare condition. Amyloid 
characterization in ocular structures should not be considered a ﬁ  nal diagnosis since involvement 
of systemic underlying diseases must be ruled out. We report a case of localized conjunctival 
amyloidosis with a ten-year follow-up period that excluded ocular or systemic diseases.
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Introduction
Amyloidosis is deﬁ  ned as the deposition of an eosinophilic hyaline protein in the tis-
sues. The classiﬁ  cation includes four types (Westermark et al 2002):
1.  Primary localized amyloidosis,
2.  Primary systemic amyloidosis,
3.  Secondary localized amyloidosis, and
4.  Secondary systemic amylodosis.
We present the case of a patient with primary localized conjunctival amyloidosis 
who showed no evidence of ocular or systemic manifestation by the amyloid after a 
ten-year follow-up period.
Case report
A systemically healthy 57-year-old female consulted our department after becoming 
concerned about a lightly colored plaque that had been present in her left eye for one 
year. The ophthalmologic examination revealed a visual acuity of 20/20. The anterior 
segment examination revealed a smooth, solid mass measuring 5 × 8 mm located in 
the stroma of the left conjunctival semilunar fold. The intraocular pressure measure-
ment was 14 mmHg for the left eye. Fundus examination was normal and the right 
eye was unaffected (Figure 1).
As a conjunctival neoplasm was suspected, a conjunctival biopsy was performed. 
The lesion was excised in its entirety. The specimen revealed a deposit of submucosal 
amorphous eosinophilic material. Congo red stain demonstrated the characteristic 
salmon pink color of these deposits. Under polarized light, the Congo red-stained 
material revealed a green birefringence characteristic of amyloid deposition. This 
reaction was eradicated by pretreatment with KMnO4, consistent with the AA (amyloid-
associated) subtype. There was no associated lymphocytic inﬁ  ltration (Figure 2).Clinical Ophthalmology 2008:2(3) 686
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Figure 1 Biomicroscopy (Left eye).
Figure 2 Amyloid characterization: Congo red-stained material revealing green birefringence diagnostic of amyloid deposition.Clinical Ophthalmology 2008:2(3) 687
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The patient underwent further systemic studies. The 
work-up included a complete blood count, urinalysis, and 
urine protein electrophoresis that were within normal limits. 
Whereas a simple needle biopsy of clinically uninvolved 
abdominal subcutaneous fat is positive in 95% of primary 
systemic amyloidosis cases, biopsies were performed in this 
case and the results were negative for Congo red staining 
(Lee et al 2000; Westermark et al 2002).
After a ten-year follow-up period, the patient has not 
shown any recurrence. There has been no evidence of ocu-
lar or systemic diseases, and no clinical or analytical data 
supporting a diagnosis of systemic amyloidosis. The patient 
remains in good health and is currently asymptomatic.
Discussion
Primary ocular amyloidosis of the eye, especially conjuncti-
val amyloidosis, is a rare clinical occurrence that is mainly 
diagnosed by histopathological examination and must be con-
sidered in the differential diagnosis of conjunctival neoplasms 
(Moorman and McDonald 1997; Lee et al 2000).
One of the characteristic features of an amyloidosis is its 
tendency to bleed. That was not a feature in our case (Lee et al 
2000; Pirouzmand et al 2002; Westermark et al 2002).
Diagnosis at an early stage is difﬁ  cult. Yellowish deposits 
are indicative of amyloidosis, but are not obvious in the early 
stages. The salmon pink color of the conjunctiva suggests a 
lymphoma or even leukaemia. Histopathologic examination 
is necessary in order to determine the ﬁ  nal diagnosis, as this 
is the only way to demonstrate amyloid material in tissue 
(Rosenblatt et al 1986; Pirouzmand et al 2002).
The mere recognition of an amyloid in an ocular struc-
ture should not be considered a complete diagnosis. The 
possibility of amyloidosis in extraocular sites associated 
with underlying diseases or immunoglobulin abnormalities 
must be considered (Lee et al 2000; Pirouzmand et al 2002; 
Westermark et al 2002). This possibility has been ruled 
out in our case after ten years of periodic investigation for 
systemic diseases.
To our knowledge, this is the ﬁ  rst case of conjunctival 
amyiloidosis with ten years of documented work-up exclud-
ing ocular or systemic diseases.
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